PVmed is a leader in the field of medical artificial intelligence (AI) technology.
It owns a world-leading technique of medical imaging AI with the highest resolution image database and largest algorithm accumulation, standing out among its international peer companies.
The company owns leading nasopharyngeal carcinoma radiotherapy targeting delineation scheme, lung disease analysis program, breast cancer detection and diagnosis system, liver cancer detection auxiliary diagnosis system and pathological artificial intelligence auxiliary analysis system.
In 2017, PVmed won 10 million Angel Wheel Investment, becoming the most powerful R&D company.